New York Stock Exchange in New York has photos in the Manhattan Borough of New York City.
Carlo Allegri | Reuters
Hims & Her Health Stocks fell 18% in expanded trading after investors surpassed expectations in the past and earnings, while focusing on disappointing gross margins.
This is how the company works:
- Earnings per share: 11 cents, 10 cents lseg expectation
- income: $481 million vs. $470 million lseg expectation
According to the press release, the telemedicine company’s revenue rose 95% from $246.6 million in the same period last year.
However, the company’s gross margin or profit remaining after selling goods is 77%, while analysts who vote on street notes are expected to have 78.4%.
This is Hims & her second largest stock, within a few days. stock Fall 26% Friday after the U.S. Food and Drug Administration Announce The shortage of Semaglutide injection products has been resolved.
In May, Hims & Hers began prescribing more complex Semaglutide, an active ingredient Novo NordiskOzempic and Wegovy’s large tablets of GLP-1 drug. The company is Breakthrough Star In the digital health sector in 2024, partly due to the success of its popular new weight loss products. Stocks climbed about 200% over the year.
Complex drugs are custom alternatives to branded drugs designed to meet the needs of specific patients and allow compounds to produce them in branded treatments. shortage. The FDA said Friday it will start taking action against the compounds within the next 60 to 90 days.
Hims & hers also offers treatments for skin care, mental health, sexual health and hair care.
CFO Yemi Okupe said in a press release that revenues rose 43% in addition to its GLP-1 products to $1.2 billion for the full year.
“The success we experience directly reflects our ability to improve and enable us to obtain high-quality, personalized care in every major,” Okupe said.
Net income climbed to $1.25 million a year ago, or 1% per share, to 11 cents a share, or 11 cents a share. According to StreetAccount, the company reported adjusted earnings of $54.1 million.
In the first quarter, Hims & Hers is expected to report $520 million to $540 million in revenue, while analysts are expected to have $497 million. The company said adjusted revenue would be between $55 million and $65 million during the period.
Hims & hers will host a quarterly call with investors at 5:00 PM ET.
-CNBC’s Brandon Gomez contributed to this report
